What sector does Alnylam Pharmaceuticals, Inc (ALNY) operate in?
Alnylam Pharmaceuticals, Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Alnylam Pharmaceuticals, Inc (ALNY) current stock price?
As of the latest data, Alnylam Pharmaceuticals, Inc stock price is $279.14, with a previous close of $281.26. Alnylam Pharmaceuticals, Inc lost -$2.12 in the last trading session, representing a -0.75% loss.
What is Alnylam Pharmaceuticals, Inc (ALNY) current market capitalization?
Alnylam Pharmaceuticals, Inc market cap is approximately 37.27 billion.
What is Alnylam Pharmaceuticals, Inc (ALNY) Earnings Per Share (EPS)?
The trailing EPS is $3.97, and the forward EPS is $13.50.
What is Alnylam Pharmaceuticals, Inc (ALNY) Price-to-Earnings (P/E) ratio?
Alnylam Pharmaceuticals, Inc current P/E ratio is 70.31, with a forward P/E of 20.67.
What is Alnylam Pharmaceuticals, Inc (ALNY) EBITDA?
Alnylam Pharmaceuticals, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 304.49 million.
Does Alnylam Pharmaceuticals, Inc (ALNY) pay dividends?
No. Alnylam Pharmaceuticals, Inc does not pay a dividend.
How did Alnylam Pharmaceuticals, Inc (ALNY) perform in its most recent earnings report?
In the last report (March 31, 2026), Alnylam Pharmaceuticals, Inc posted an EPS surprise of 35.37% and a revenue surprise of 4.53%.
When is Alnylam Pharmaceuticals, Inc (ALNY) next earnings report?
Alnylam Pharmaceuticals, Inc is expected to release its next earnings report on June 30, 2026.
What is Alnylam Pharmaceuticals, Inc (ALNY) beta (volatility) score?
Alnylam Pharmaceuticals, Inc has a beta of 0.269, indicating lower volatility than the overall market.